Skip to main content

Coronavirus (COVID-19) Updates: Visitation Policies (New! 11.25.20) | How We're Keeping You Safe | Latest COVID Information

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

PBRN00002 / ANBL00B1 / Peds Neuroblastoma Biomarker / Angela Girvin

Research Question:
Can doctors identify biomarkers, a measurable substance in tissues that may predict disease, in patients with neuroblastoma or ganglioneuroblastoma?

Basic Study Information

Purpose:
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher:  Angela Girvin

Study Contact Information

Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search